An advisory committee to the Food and Drug Administration was told that unreasonable FDA restrictions on healthcare use of safe and effective antibacterial ingredients could jeopardize the safety of patients and healthcare workers alike.   In a presentation to FDA’s Nonprescription Drugs Advisory Committee (NDAC) organized by the American Cleaning Institute (ACI), health professionals and industry safety experts said that active ingredients used in antibacterial hygiene products “clearly s...